Bausch Health Companies Inc.

US$8.18As of Sun 8 Nov 2026, 12:00 UTC
NYSE:BHCHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (7.49%)
Div yield —
ROE (11040.00%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.28
PE TTM —
TSR TTM 16.52%
Mkt cap US$3.062B
ROIC 14.74%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$8.59
4.97%
(61.92%)
Hold 6|6|5|12|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.08
0.09
0.09
0.09
20.04%
25.70%
14.73%
16.33%
Revenue$M
173.8
183.7
190.1
188.4
8.45%
12.44%
17.34%
10.45%
Peers (US$3.062B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.532
0.563
0.557
EBIT/Intx
0.240
0.844
0.803
Own earn%
(67.59)
238.67
193.46
Sh yield%
21.09
29.06
27.15
Owners
Insiders/Inst%
5.20
62.48
Short interest%
1.02
SBC / revenue%
0.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
13–20
$1 testx
—
Incr. ROIC%
1